Technical Analysis for OPNT - Opiant Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 13.5 3.93% 0.51
OPNT closed up 3.93 percent on Wednesday, February 24, 2021, on 21 percent of normal volume.
Earnings due: Mar 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical OPNT trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
20 DMA Support Bullish 3.93%
Hammer Candlestick Bullish 3.93%
1,2,3 Pullback Bullish Bullish Swing Setup 3.93%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.93%
Wide Bands Range Expansion 3.93%
Down 3 Days in a Row Weakness 3.93%
MACD Bearish Signal Line Cross Bearish -0.74%
Wide Bands Range Expansion -0.74%
Narrow Range Bar Range Contraction -2.17%
Older End-of-Day Signals for OPNT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 13 hours ago
Up 3% about 14 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 14 hours ago
1,2,3, Pullback Entry about 14 hours ago
Hammer Candlestick Entry about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chloride Opioid FDA Organic Chemistry Xone Nasal Spray Addiction Heroin Cocaine Company's Pipeline Naloxone United States Food And Drug Administration Bulimia Nervosa Eating Disorder

Is OPNT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.9754
52 Week Low 6.7878
Average Volume 79,665
200-Day Moving Average 9.20
50-Day Moving Average 10.33
20-Day Moving Average 12.89
10-Day Moving Average 13.86
Average True Range 0.81
ADX 59.37
+DI 27.74
-DI 17.23
Chandelier Exit (Long, 3 ATRs ) 12.54
Chandelier Exit (Short, 3 ATRs ) 11.83
Upper Bollinger Band 15.51
Lower Bollinger Band 10.26
Percent B (%b) 0.62
BandWidth 40.72
MACD Line 1.02
MACD Signal Line 1.17
MACD Histogram -0.1535
Fundamentals Value
Market Cap 57.48 Million
Num Shares 4.26 Million
EPS 1.79
Price-to-Earnings (P/E) Ratio 7.53
Price-to-Sales 1.41
Price-to-Book 1.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.51
Resistance 3 (R3) 14.45 14.06 14.34
Resistance 2 (R2) 14.06 13.80 14.09 14.29
Resistance 1 (R1) 13.78 13.64 13.92 13.84 14.23
Pivot Point 13.39 13.39 13.46 13.42 13.39
Support 1 (S1) 13.11 13.13 13.25 13.16 12.77
Support 2 (S2) 12.71 12.97 12.74 12.71
Support 3 (S3) 12.43 12.71 12.66
Support 4 (S4) 12.49